Bosutinib
Category: CancerBosutinib Overview
Bosutinib (rINN/USAN; codenamed SKI-606, marketed under the trade name Bosulif) is a small molecule BCR-ABL and src tyrosine kinase inhibitor used for the treatment of chronic myelogenous leukemia. Originally synthesized by Wyeth, it is being developed by Pfizer. Contents 1 Mechanism 2 Medical uses 3 Adverse effects 3.1 Contraindications 3.2 Interactions 3.3 Carcinogenicity and mutagenicity 4 Quality issues 5 Notes 6 See also 7 References 8 External links Mechanism It is an ATP-com...
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Bosutinib
Recent Bosutinib Forums:
Be the first to start a discussion about this drug.Possible Dosages for this and Related Drugs:
Bosutinib
- Tablet: 100mg, 400mg, 500mg
Other drugs which contain Bosutinib or a similar ingredient: (1 result)
- BOSULIF Bosutinib3 discussions